🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to investigate the efficacy of nemol...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01
Trial ID
NCT05056779
Treatments Being Tested
The purpose of this study was to evaluate the pharmacokinetics and safety o...
Status
Completed
Location
Galderma Investigational Site
Start Date
2019-04-09
Trial ID
NCT03921411
Treatments Being Tested
The aim of this study is to assess the safety and efficacy of nemolizumab i...
Status
Completed
Location
LKH-Univ. Klinikum Graz
Start Date
2017-10-02
Trial ID
NCT03181503
Treatments Being Tested
The primary objective was to assess the efficacy of nemolizumab (CD14152) c...
Status
Completed
Location
Galderma Investigational Site
Start Date
2020-09-11
Trial ID
NCT04501666
Treatments Being Tested
The main objective of this study is to assess the long-term durability of r...
Status
Completed
Location
Galderma Investigational Site 8521
Start Date
2022-01-24
Trial ID
NCT05052983
Treatments Being Tested
The primary objective of the study is to assess the pharmacokinetics (PK) a...
Status
Recruiting
Location
Texas Dermatology and Laser Specialist-San Antonio
Start Date
2026-07-13
Trial ID
NCT07660835
Treatments Being Tested
The primary objective was to assess the efficacy of nemolizumab (CD14152) c...
Status
Completed
Location
Galderma Investigational Site
Start Date
2020-08-11
Trial ID
NCT04501679
Treatments Being Tested
This is a bridging study only for Chinese subjects. The goal of this clinic...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-28
Trial ID
NCT07762833
Treatments Being Tested
The purpose of this study was to evaluate the efficacy of nemolizumab compa...
Status
Completed
Location
Galderma Investigational Site 9989
Start Date
2022-03-18
Trial ID
NCT05075408
Treatments Being Tested
The purpose of this study is to evaluate the effect of nemolizumab (CD14152...
Status
Completed
Location
8894 Galderma Investigational Site
Start Date
2021-12-08
Trial ID
NCT04562116
Treatments Being Tested